AAPL340.54+1.56 (+0.46%) ▲|ABBV265.77+1.29 (+0.49%) ▲|ABT104.21+1.23 (+1.19%) ▲|ACN185.46-0.65 (-0.35%) ▼|ADBE238.64-10.88 (-4.36%) ▼|AMAT471.91+7.67 (+1.65%) ▲|AMD621.54+6.02 (+0.98%) ▲|AMGN410.07+16.91 (+4.30%) ▲|AMT175.64+1.04 (+0.60%) ▲|AMZN256.06-2.39 (-0.92%) ▼|AVGO365.22+2.56 (+0.71%) ▲|AXP306.68-6.91 (-2.20%) ▼|BA198.01-3.15 (-1.56%) ▼|BAC56.54-1.43 (-2.46%) ▼|BKNG162.45-6.07 (-3.60%) ▼|BLK1,069.39-20.88 (-1.92%) ▼|BMY62.41-0.21 (-0.34%) ▼|BNY150.51-3.38 (-2.20%) ▼|BRK-B504.39+2.38 (+0.47%) ▲|C133.06-1.99 (-1.47%) ▼|CAT807.66-8.84 (-1.08%) ▼|CL86.97+0.71 (+0.82%) ▲|CMCSA22.48-0.46 (-1.98%) ▼|COF201.73-3.19 (-1.56%) ▼|COP125.71-1.82 (-1.43%) ▼|COST898.80+0.32 (+0.04%) ▲|CRM233.80-2.63 (-1.11%) ▼|CSCO106.08-5.38 (-4.83%) ▼|CVS87.21-0.39 (-0.45%) ▼|CVX202.65-1.02 (-0.50%) ▼|DE701.33+16.60 (+2.42%) ▲|DHR221.46+5.62 (+2.60%) ▲|DIS104.10-0.13 (-0.12%) ▼|DUK116.46-0.29 (-0.24%) ▼|EMR154.49+2.77 (+1.83%) ▲|FDX296.39+0.60 (+0.20%) ▲|GD344.10-9.80 (-2.77%) ▼|GE319.50+0.49 (+0.15%) ▲|GEV950.46+4.24 (+0.45%) ▲|GILD152.78+2.22 (+1.47%) ▲|GM83.77-0.19 (-0.22%) ▼|GOOG348.00-2.87 (-0.82%) ▼|GOOGL352.05-2.93 (-0.82%) ▼|GS952.91-6.48 (-0.68%) ▼|HD305.96+8.76 (+2.95%) ▲|HON211.79+5.31 (+2.57%) ▲|IBM232.58+0.65 (+0.28%) ▲|INTC123.22+1.44 (+1.18%) ▲|INTU291.78-12.35 (-4.06%) ▼|ISRG402.29+0.64 (+0.16%) ▲|JNJ269.66+0.19 (+0.07%) ▲|JPM340.43-11.61 (-3.30%) ▼|KO88.93+1.81 (+2.07%) ▲|LIN465.29+7.79 (+1.70%) ▲|LLY1,175.07+10.18 (+0.87%) ▲|LMT521.58-13.82 (-2.58%) ▼|LOW196.27+5.29 (+2.77%) ▲|LRCX309.92+7.64 (+2.53%) ▲|MA557.70-9.96 (-1.75%) ▼|MCD251.05+3.17 (+1.28%) ▲|MDLZ61.13+0.96 (+1.59%) ▲|MDT90.84-0.91 (-0.99%) ▼|META738.12-3.13 (-0.42%) ▼|MMM168.79+3.82 (+2.32%) ▲|MO68.91+0.38 (+0.55%) ▲|MRK151.43+1.93 (+1.29%) ▲|MS200.38-5.74 (-2.78%) ▼|MSFT499.02-2.59 (-0.52%) ▼|MU1,093.90+49.94 (+4.78%) ▲|NEE79.47-0.16 (-0.20%) ▼|NFLX72.11-1.26 (-1.71%) ▼|NKE36.19+0.09 (+0.24%) ▲|NOW137.86+0.18 (+0.13%) ▲|NVDA229.29+1.91 (+0.84%) ▲|ORCL149.48+0.92 (+0.62%) ▲|PEP131.31+1.72 (+1.33%) ▲|PFE27.94+0.20 (+0.70%) ▲|PG148.09+2.01 (+1.38%) ▲|PLTR184.76+1.69 (+0.92%) ▲|PM191.75+4.27 (+2.28%) ▲|QCOM197.65+3.42 (+1.76%) ▲|RTX191.47-2.87 (-1.48%) ▼|SBUX95.15+0.25 (+0.26%) ▲|SCHW100.69-6.19 (-5.79%) ▼|SO85.20-0.26 (-0.30%) ▼|SPG205.77+0.79 (+0.39%) ▲|T25.14-0.32 (-1.24%) ▼|TMO658.72-0.04 (-0.01%) ▼|TMUS162.72-2.55 (-1.54%) ▼|TSLA379.62+4.41 (+1.17%) ▲|TXN271.20+0.33 (+0.12%) ▲|UBER70.00-0.84 (-1.19%) ▼|UNH373.21-4.35 (-1.15%) ▼|UNP274.70+5.07 (+1.88%) ▲|UPS96.04+1.29 (+1.36%) ▲|USB59.41-1.03 (-1.70%) ▼|V362.60-7.35 (-1.99%) ▼|VZ46.49-1.20 (-2.51%) ▼|WFC83.37-3.18 (-3.67%) ▼|WMT110.06+2.62 (+2.44%) ▲|XOM159.01+0.71 (+0.45%) ▲|AAPL340.54+1.56 (+0.46%) ▲|ABBV265.77+1.29 (+0.49%) ▲|ABT104.21+1.23 (+1.19%) ▲|ACN185.46-0.65 (-0.35%) ▼|ADBE238.64-10.88 (-4.36%) ▼|AMAT471.91+7.67 (+1.65%) ▲|AMD621.54+6.02 (+0.98%) ▲|AMGN410.07+16.91 (+4.30%) ▲|AMT175.64+1.04 (+0.60%) ▲|AMZN256.06-2.39 (-0.92%) ▼|AVGO365.22+2.56 (+0.71%) ▲|AXP306.68-6.91 (-2.20%) ▼|BA198.01-3.15 (-1.56%) ▼|BAC56.54-1.43 (-2.46%) ▼|BKNG162.45-6.07 (-3.60%) ▼|BLK1,069.39-20.88 (-1.92%) ▼|BMY62.41-0.21 (-0.34%) ▼|BNY150.51-3.38 (-2.20%) ▼|BRK-B504.39+2.38 (+0.47%) ▲|C133.06-1.99 (-1.47%) ▼|CAT807.66-8.84 (-1.08%) ▼|CL86.97+0.71 (+0.82%) ▲|CMCSA22.48-0.46 (-1.98%) ▼|COF201.73-3.19 (-1.56%) ▼|COP125.71-1.82 (-1.43%) ▼|COST898.80+0.32 (+0.04%) ▲|CRM233.80-2.63 (-1.11%) ▼|CSCO106.08-5.38 (-4.83%) ▼|CVS87.21-0.39 (-0.45%) ▼|CVX202.65-1.02 (-0.50%) ▼|DE701.33+16.60 (+2.42%) ▲|DHR221.46+5.62 (+2.60%) ▲|DIS104.10-0.13 (-0.12%) ▼|DUK116.46-0.29 (-0.24%) ▼|EMR154.49+2.77 (+1.83%) ▲|FDX296.39+0.60 (+0.20%) ▲|GD344.10-9.80 (-2.77%) ▼|GE319.50+0.49 (+0.15%) ▲|GEV950.46+4.24 (+0.45%) ▲|GILD152.78+2.22 (+1.47%) ▲|GM83.77-0.19 (-0.22%) ▼|GOOG348.00-2.87 (-0.82%) ▼|GOOGL352.05-2.93 (-0.82%) ▼|GS952.91-6.48 (-0.68%) ▼|HD305.96+8.76 (+2.95%) ▲|HON211.79+5.31 (+2.57%) ▲|IBM232.58+0.65 (+0.28%) ▲|INTC123.22+1.44 (+1.18%) ▲|INTU291.78-12.35 (-4.06%) ▼|ISRG402.29+0.64 (+0.16%) ▲|JNJ269.66+0.19 (+0.07%) ▲|JPM340.43-11.61 (-3.30%) ▼|KO88.93+1.81 (+2.07%) ▲|LIN465.29+7.79 (+1.70%) ▲|LLY1,175.07+10.18 (+0.87%) ▲|LMT521.58-13.82 (-2.58%) ▼|LOW196.27+5.29 (+2.77%) ▲|LRCX309.92+7.64 (+2.53%) ▲|MA557.70-9.96 (-1.75%) ▼|MCD251.05+3.17 (+1.28%) ▲|MDLZ61.13+0.96 (+1.59%) ▲|MDT90.84-0.91 (-0.99%) ▼|META738.12-3.13 (-0.42%) ▼|MMM168.79+3.82 (+2.32%) ▲|MO68.91+0.38 (+0.55%) ▲|MRK151.43+1.93 (+1.29%) ▲|MS200.38-5.74 (-2.78%) ▼|MSFT499.02-2.59 (-0.52%) ▼|MU1,093.90+49.94 (+4.78%) ▲|NEE79.47-0.16 (-0.20%) ▼|NFLX72.11-1.26 (-1.71%) ▼|NKE36.19+0.09 (+0.24%) ▲|NOW137.86+0.18 (+0.13%) ▲|NVDA229.29+1.91 (+0.84%) ▲|ORCL149.48+0.92 (+0.62%) ▲|PEP131.31+1.72 (+1.33%) ▲|PFE27.94+0.20 (+0.70%) ▲|PG148.09+2.01 (+1.38%) ▲|PLTR184.76+1.69 (+0.92%) ▲|PM191.75+4.27 (+2.28%) ▲|QCOM197.65+3.42 (+1.76%) ▲|RTX191.47-2.87 (-1.48%) ▼|SBUX95.15+0.25 (+0.26%) ▲|SCHW100.69-6.19 (-5.79%) ▼|SO85.20-0.26 (-0.30%) ▼|SPG205.77+0.79 (+0.39%) ▲|T25.14-0.32 (-1.24%) ▼|TMO658.72-0.04 (-0.01%) ▼|TMUS162.72-2.55 (-1.54%) ▼|TSLA379.62+4.41 (+1.17%) ▲|TXN271.20+0.33 (+0.12%) ▲|UBER70.00-0.84 (-1.19%) ▼|UNH373.21-4.35 (-1.15%) ▼|UNP274.70+5.07 (+1.88%) ▲|UPS96.04+1.29 (+1.36%) ▲|USB59.41-1.03 (-1.70%) ▼|V362.60-7.35 (-1.99%) ▼|VZ46.49-1.20 (-2.51%) ▼|WFC83.37-3.18 (-3.67%) ▼|WMT110.06+2.62 (+2.44%) ▲|XOM159.01+0.71 (+0.45%) ▲|
19.5 C
New York
Tuesday, September 22, 2026

Tag: opportunities

newssourceFORcompanyinformationcontent1releasesmarket

NurExone Advances U.S. Growth Strategy with Acceptance into Prestigious ARMI HealthTech Hub Accelerator and Provides Corporate Update

TORONTO and HAIFA, Israel, June 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biotech company developing exosome-based therapies for central nervous system injuries, announced today that it has been accepted into the HealthTech Hub (“HTH”) Accelerator Program. Based in Boston, Massachusetts, home to more than 1,000 biotech companies1, HTH is operated by the Advanced Regenerative Manufacturing Institute (“ARMI”) and its BioFabUSA initiative.

Deakin University GIFT City Campus, India, announced ‘Winner’ at Economic Times Education Excellence Awards 2025

NEW DELHI, June 20, 2025 /PRNewswire/ -- Deakin University is proud to announce that its GIFT City Campus in Gandhinagar, India, has been awarded...

RSI Momentum Breakout Strategy: Overbought/Oversold Zone Analysis

OverviewThe RSI Overbought/Oversold Zone Momentum Breakout Strategy is designed to harness market momentum shifts using the Relative Strength Index (RSI). This strategy identifies breakout...

Prosthetic Eye Market Innovation—Evaluating Investment in Specialized Medical Devices

Christina Leitzel, renowned in the niche field of ocular prosthetics, approaches her craft with precision akin to that of an art forger. This meticulous...

Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system

The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+This year marks the 30-year anniversary since...

Key Investment Principles from The Intelligent Investor: Evidence-Based Analysis

In a May 2025 appearance on Morningstar's The Long View podcast, Wall Street Journal columnist Jason Zweig provided crucial insights for investors facing significant...

OMS Energy Technologies Inc. Issues Post-IPO Operational Update Featuring Customer Growth, Expansion Initiatives and R&D and Safety Achievements

SINGAPORE, June 19, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (Nasdaq: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today provided a business update outlining its recent accomplishments as the Company prepares for its inaugural earnings call following its successful Nasdaq listing in May 2025.

BingX New Dual Investment Offering Sees $1M in User Participation

PANAMA CITY, June 20, 2025 /PRNewswire/ -- BingX, a leading cryptocurrency exchange and Web3 AI company, has officially launched its Dual Investment product, aimed...

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025

MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting being held in New Orleans, Louisiana (U.S.) from June 21 – 24.

Shipsy to Drive Rapid Expansion in Australia, Establishes Regional Headquarters in Sydney to Support Growing Client Base

SYDNEY, June 20, 2025 /PRNewswire/ -- Shipsy, a Gartner-recognized global leader in AI-powered SaaS-based logistics management platform provider, recently announced its plans to aggressively...

Cargojet Announces Inaugural Issuer Credit Rating of BBB (low) With a Stable Trend by Morningstar DBRS

MISSISSAUGA, ON, June 19, 2025 /CNW/ - Cargojet Inc. ("Cargojet" or the "Corporation") (TSX: CJT) today announced that Morningstar DBRS has assigned the Corporation...

ICW Group Insurance Companies Launches New Business Unit, ICW Specialty

SAN DIEGO, June 19, 2025 /PRNewswire/ -- ICW Group Insurance Companies is thrilled to announce the launch of ICW Specialty, a new business unit...

HER2-low Cancers Market Set to Register Immense Growth at a CAGR of 9.4% During the Study Period (2020-2034) | DelveInsight

The future of the HER2-low cancer treatment market is poised for significant transformation, driven by the approval of ENHERTU and the advancement of other...

Costa Rica Strengthens Its Position as a Regional Hub for the Audiovisual Industry with New Regional Market

Costa Rica Media Market will take place June 24–25 in San José, with over 500 business meetings and participation from buyers, producers, and experts...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOpportunities

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers